2020
DOI: 10.1002/cbic.202000212
|View full text |Cite
|
Sign up to set email alerts
|

Stapled Peptide Inhibitors of Autophagy Adapter LC3B

Abstract: A growing body of evidence suggests that autophagy inhibition enhances the effectiveness of chemotherapy, especially in difficult-to-treat cancers. Existing autophagy inhibitors are primarily lysosomotropic agents. More specific autophagy inhibitors are highly sought-after. The microtubule-associated protein 1A/1B light chain 3B protein, LC3B, is an adapter protein that mediates key protein-protein interactions at several points in autophagy pathways. In this work, we used a known peptide ligand as a starting … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 84 publications
0
18
0
Order By: Relevance
“…Covalent linking of side chains, or “peptide stapling,” is a promising strategy to minimize these limitations . While most stapled peptides are α-helical, we and others have shown that appropriately designed staples can improve the properties of peptides in other conformations as well. , Based on the crystal structure of K1 bound to GABARAP, we designed peptides Cys5, Cys4, and Cys3, which stapled K1 in ( i , i + 3), ( i , i + 4), and ( i , i + 5) positions, respectively (Figure a). We stapled each peptide using dithiol bis-alkylation with ortho- , meta- , and para- dimethylbenzene linkers, allowing for a “diversity-oriented stapling” approach, where the staple geometry was varied (Figure a). ,, Stapling in ( i , i + 3) positions (the Cys5 peptides) reduced binding to both GABARAP and LC3B compared to K1.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Covalent linking of side chains, or “peptide stapling,” is a promising strategy to minimize these limitations . While most stapled peptides are α-helical, we and others have shown that appropriately designed staples can improve the properties of peptides in other conformations as well. , Based on the crystal structure of K1 bound to GABARAP, we designed peptides Cys5, Cys4, and Cys3, which stapled K1 in ( i , i + 3), ( i , i + 4), and ( i , i + 5) positions, respectively (Figure a). We stapled each peptide using dithiol bis-alkylation with ortho- , meta- , and para- dimethylbenzene linkers, allowing for a “diversity-oriented stapling” approach, where the staple geometry was varied (Figure a). ,, Stapling in ( i , i + 3) positions (the Cys5 peptides) reduced binding to both GABARAP and LC3B compared to K1.…”
Section: Resultsmentioning
confidence: 99%
“…23−25 In previous work, we described structure-activity relationships for an LC3specific LIR motif derived from FYCO1, a Rab7 effector protein that mediates autophagosome trafficking. 26 We also described peptides with side-chain-to-side-chain crosslinks, or "stapled" peptides, with improved affinity, selectivity for LC3B over GABARAP, proteolytic stability, and cytosolic delivery. In this work, we report two new classes of stapled peptides that inhibit LC3/GABARAP proteins with nanomolar affinity, one GABARAP-selective class and another that inhibits both subfamilies.…”
Section: ■ Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, we attempted to clarify whether DAPA activated autophagy pathway and the AMPK/mTOR signaling. LC3B is an adapter protein mediating vital protein-protein interactions in autophagy pathways [ 21 ]. Thus, we examined LC3B expression changes in myocardial tissue of rats using IHC.…”
Section: Resultsmentioning
confidence: 99%
“…One of the potential advantages of incorporating non-proteinogenic amino acids and covalent staples is resistance to proteolytic degradation. To test whether the designed β-hairpins were stable to degradation, we adapted a cell lysate stability assay recently applied for development of olefin-stapled α-helices. Because HeLa cell lysate contains all cellular proteases including lysosomal proteases, this represents a relatively rigorous test for metabolic stability of peptide therapeutics. Control peptides HP7 and ΔHP7 were degraded rapidly, with roughly 0% and 19%, respectively, remaining after only 2 h (Figure a).…”
Section: Results and Discussionmentioning
confidence: 99%